228 related articles for article (PubMed ID: 3565366)
1. The association of oil ingestion with toxic oil syndrome in two convents.
Diaz de Rojas F; Castro García M; Abaitua Borda I; Alonso Gordo JM; Posada de la Paz M; Kilbourne EM; Tabuenca Oliver JM
Am J Epidemiol; 1987 May; 125(5):907-11. PubMed ID: 3565366
[TBL] [Abstract][Full Text] [Related]
2. Chemical correlates of pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
Kilbourne EM; Bernert JT; Posada de la Paz M; Hill RH; Abaitua Borda I; Kilbourne BW; Zack MM
Am J Epidemiol; 1988 Jun; 127(6):1210-27. PubMed ID: 3369420
[TBL] [Abstract][Full Text] [Related]
3. Toxic oil syndrome: traceback of the toxic oil and evidence for a point source epidemic.
Posada de la Paz M; Philen RM; Borda IA; Sicilia Socias JM; Gómez de la Cámara A; Kilbourne EM
Food Chem Toxicol; 1996 Mar; 34(3):251-7. PubMed ID: 8621106
[TBL] [Abstract][Full Text] [Related]
4. Oil ingestion and the toxic-oil syndrome: results of a survey of residents of the Orcasur neighbourhood in Madrid, Spain.
Cañas R; Kilbourne EM
Int J Epidemiol; 1987 Mar; 16(1):3-6. PubMed ID: 3570618
[TBL] [Abstract][Full Text] [Related]
5. Factors associated with pathogenicity of oils related to the toxic oil syndrome epidemic in Spain.
Posada de la Paz M; Philen RM; Abaitua Borda I; Diez Ruiz-Navarro M; Abraira Santos V; Pozo Rodríguez F; Pla Mestre R; Pollán Santamaría M; Sicilia Socias JM; Azpeitia Gamazo P
Epidemiology; 1994 Jul; 5(4):404-9. PubMed ID: 7918809
[TBL] [Abstract][Full Text] [Related]
6. Spanish toxic oil syndrome: ten years after the disaster.
Ortega-Benito JM
Public Health; 1992 Jan; 106(1):3-9. PubMed ID: 1603915
[TBL] [Abstract][Full Text] [Related]
7. Toxic oil syndrome: the perspective after 20 years.
Posada de la Paz M; Philen RM; Borda AI
Epidemiol Rev; 2001; 23(2):231-47. PubMed ID: 12192735
[TBL] [Abstract][Full Text] [Related]
8. Toxic-oil syndrome: case reports associated with the ITH oil refinery in Sevilla.
Posada M; Castro M; Kilbourne EM; Diaz de Rojas F; Abaitua I; Tabuenca JM; Vioque A
Food Chem Toxicol; 1987 Jan; 25(1):87-90. PubMed ID: 3817664
[TBL] [Abstract][Full Text] [Related]
9. Toxic oil syndrome: a current clinical and epidemiologic summary, including comparisons with the eosinophilia-myalgia syndrome.
Kilbourne EM; Posada de la Paz M; Abaitua Borda I; Diez Ruiz-Navarro M; Philen RM; Falk H
J Am Coll Cardiol; 1991 Sep; 18(3):711-7. PubMed ID: 1869734
[TBL] [Abstract][Full Text] [Related]
10. Seminar on cardiovascular manifestations of the toxic oil syndrome and related conditions.
Bruschke AV; James TN
J Am Coll Cardiol; 1991 Sep; 18(3):707-10. PubMed ID: 1869733
[No Abstract] [Full Text] [Related]
11. Detection and isolation of pentachlorophenol in oil samples associated with the Spanish toxic oil syndrome.
Guitart R; Abián J; Arboix M; Gelpí E
Bull Environ Contam Toxicol; 1990 Aug; 45(2):181-8. PubMed ID: 2400832
[No Abstract] [Full Text] [Related]
12. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Silver RM
Curr Opin Rheumatol; 1993 Nov; 5(6):802-8. PubMed ID: 8117543
[TBL] [Abstract][Full Text] [Related]
13. Toxicologists versus toxicological disasters: toxic oil syndrome, clinical aspects.
Gómez de la Cámara A; Abaitua Borda I; Posada de la Paz M
Arch Toxicol Suppl; 1997; 19():31-40. PubMed ID: 9079192
[No Abstract] [Full Text] [Related]
14. Late cases of toxic oil syndrome: evidence that the aetiological agent persisted in oil stored for up to one year.
Posada de la Paz M; Abaitua Borda I; Kilbourne EM; Tabuenca Oliver JM; Diaz de Rojas F; Castro Garcia M
Food Chem Toxicol; 1989 Aug; 27(8):517-21. PubMed ID: 2792975
[TBL] [Abstract][Full Text] [Related]
15. 3-(Phenylamino)alanine--a link between eosinophilia-myalgia syndrome and toxic oil syndrome?
Philen RM; Hill RH
Mayo Clin Proc; 1993 Feb; 68(2):197-200. PubMed ID: 8423703
[No Abstract] [Full Text] [Related]
16. Possible etiologic agents for toxic oil syndrome: fatty acid esters of 3-(N-phenylamino)-1,2-propanediol.
Hill RH; Schurz HH; Posada de la Paz M; Abaitua Borda I; Philen RM; Kilbourne EM; Head SL; Bailey SL; Driskell WJ; Barr JR
Arch Environ Contam Toxicol; 1995 Feb; 28(2):259-64. PubMed ID: 7710294
[TBL] [Abstract][Full Text] [Related]
17. Biotransformation of 3-(phenylamino)-1,2-propanediol to 3-(phenylamino)alanine: a chemical link between toxic oil syndrome and eosinophilia-myalgia syndrome.
Mayeno AN; Benson LM; Naylor S; Colberg-Beers M; Puchalski JT; Gleich GJ
Chem Res Toxicol; 1995; 8(7):911-6. PubMed ID: 8555405
[TBL] [Abstract][Full Text] [Related]
18. Epidemiologic evidence for a new class of compounds associated with toxic oil syndrome.
Posada de la Paz M; Philen RM; Schurz H; Hill RH; Giménez Ribota O; Gómez de la Camara A; Kilbourne EM; Abaitua I
Epidemiology; 1999 Mar; 10(2):130-4. PubMed ID: 10069247
[TBL] [Abstract][Full Text] [Related]
19. Eosinophilia-myalgia syndrome, toxic-oil syndrome, and diffuse fasciitis with eosinophilia.
Bolster MB; Silver RM
Curr Opin Rheumatol; 1994 Nov; 6(6):642-9. PubMed ID: 7865387
[TBL] [Abstract][Full Text] [Related]
20. Chemical-induced autoimmune reactions and Spanish toxic oil syndrome. Focus on hydantoins and related compounds.
Kammüller ME; Bloksma N; Seinen W
J Toxicol Clin Toxicol; 1988; 26(3-4):157-74. PubMed ID: 3047417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
